ReportWire

Tag: wsjfinance-ws

  • WSJ News Exclusive | Hewlett Packard Enterprise Near Deal to Buy Juniper Networks

    WSJ News Exclusive | Hewlett Packard Enterprise Near Deal to Buy Juniper Networks

    [ad_1]

    Updated Jan. 8, 2024 6:31 pm ET

    Hewlett Packard Enterprise is in advanced talks to buy Juniper Networks for about $13 billion, in a bid to better position the nearly 100-year-old technology company in the era of artificial intelligence. 

    A deal between the two companies could be announced as soon as this week, according to people familiar with the matter, assuming the talks don’t fall apart. 

    Copyright ©2024 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

    [ad_2]

    Source link

  • WSJ News Exclusive | Cigna Calls Off Humana Pursuit, Plans Big Stock Buyback

    WSJ News Exclusive | Cigna Calls Off Humana Pursuit, Plans Big Stock Buyback

    [ad_1]

    Updated Dec. 10, 2023 4:47 pm ET

    Cigna Group abandoned its pursuit of a tie-up with Humana after shareholders balked at a deal that would have created a roughly $140 billion giant in the health-insurance industry.

    The companies couldn’t come to agreement on price and other financial terms, according to people familiar with the matter. In the near term, Cigna is turning its focus toward smaller, so-called bolt-on, acquisitions.

    Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

    [ad_2]

    Source link

  • WSJ News Exclusive | Hedge Fund Two Sigma Is Hit by Trading Scandal

    WSJ News Exclusive | Hedge Fund Two Sigma Is Hit by Trading Scandal

    [ad_1]

    A researcher at Two Sigma Investments adjusted the hedge fund’s investing models without authorization, the firm has told clients, leading to losses in some funds, big gains in others and fresh regulatory scrutiny.

    The researcher, Jian Wu, a senior vice president at New York-based Two Sigma, was trying to boost his compensation, Two Sigma has told clients, without identifying Wu. He made changes over the past year that resulted in a total of $620 million in unexpected gains and losses, according to people close to the matter and investor letters. Two Sigma has placed Wu on administrative leave.

    Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

    [ad_2]

    Source link

  • America’s Biggest Bank Is Everywhere—and It Isn’t Done Growing

    America’s Biggest Bank Is Everywhere—and It Isn’t Done Growing

    [ad_1]

    This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by
    our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact
    Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.

    https://www.wsj.com/articles/americas-biggest-bank-is-everywhereand-it-isnt-done-growing-5ff18360

    [ad_2]

    Source link

  • PacWest Stock Surges 82%, Regional Banks Recover After Selloff

    PacWest Stock Surges 82%, Regional Banks Recover After Selloff

    [ad_1]

    [ad_2]
    Source link

  • First Republic Lost $100 Billion in Deposits in Banking Panic

    First Republic Lost $100 Billion in Deposits in Banking Panic

    [ad_1]

    First Republic Lost $100 Billion in Deposits in Banking Panic

    [ad_2]

    Source link

  • Moody’s Downgrades 11 Regional Banks, Including Zions, U.S. Bank, Western Alliance

    Moody’s Downgrades 11 Regional Banks, Including Zions, U.S. Bank, Western Alliance

    [ad_1]

    Moody’s Downgrades 11 Regional Banks, Including Zions, U.S. Bank, Western Alliance

    [ad_2]

    Source link

  • WSJ News Exclusive | Amgen in Advanced Talks to Buy Horizon Therapeutics

    WSJ News Exclusive | Amgen in Advanced Talks to Buy Horizon Therapeutics

    [ad_1]

    U.S. biotechnology company was the last of three suitors standing in an auction for Horizon

    [ad_2]
    Source link

  • WSJ News Exclusive | Bio-Rad Laboratories in Talks to Combine With Qiagen

    WSJ News Exclusive | Bio-Rad Laboratories in Talks to Combine With Qiagen

    [ad_1]

    Bio-Rad Laboratories is in talks to combine with fellow life-sciences company Qiagen NV in a deal that would be worth more than $10 billion, according to people familiar with the matter.

    The talks have been going on for a while but any agreement isn’t likely for another few weeks or more—and there may not be one.

    [ad_2]

    Source link